Certified by Founder Lodge
Logos Capital
United States - Miami, Florida
INVESTOR
1 Disclosed Funding Rounds $41,500,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Logos Capital* is a global merchant finance firm focused on catalyzing regenerative revolutions Ecopreneurship through Venture Capital, Private Equity with nextgen family offices and blockcha
Company | Date | Round | Raised |
---|---|---|---|
Parse Biosciences | February, 15 ,2022 | Series B | $41,500,000 |
Boundless Bio | May, 17 ,2023 | Series C | $100,000,000 |
Septerna | July, 18 ,2023 | Series B | $150,000,000 |
Mirador Therapeutics | March, 26 ,2024 | Unknown | $400,000,000 |
Scorpion Therapeutics | July, 17 ,2024 | Series C | $150,000,000 |
858 Therapeutics | September, 27 ,2024 | Series B | $50,000,000 |
Adcendo | November, 26 ,2024 | Series B | $135,000,000 |
Maze Therapeutics | December, 04 ,2024 | Series D | $115,000,000 |